Title : Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.

Pub. Date : 2020 Apr

PMID : 31863490






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We have studied the expression levels of one of these antiviral effectors, TRIM22 in response to sofosbuvir (SOF) and daclatasvir (DAC) in combination with RBV, using quantitative PCR in the peripheral blood mononuclear cells (PBMCs) of HCV-infected patients. daclatasvir tripartite motif containing 22 Homo sapiens
2 We have studied the expression levels of one of these antiviral effectors, TRIM22 in response to sofosbuvir (SOF) and daclatasvir (DAC) in combination with RBV, using quantitative PCR in the peripheral blood mononuclear cells (PBMCs) of HCV-infected patients. daclatasvir tripartite motif containing 22 Homo sapiens